Epidemiology and endocrinology of benign breast disease.
D000232:Adenofibroma / Q000150:complications / Q000453:epidemiology* / Q000378:metabolism; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000728:Androgens / Q000378:metabolism; D001943:Breast Neoplasms / Q000150:complications / Q000453:epidemiology* / Q000235:genetics / Q000378:metabolism; D002272:Carcinoembryonic Antigen / Q000378:metabolism; D003276:Contraceptives, Oral / Q000009:adverse effects; D004967:Estrogens / Q000378:metabolism; D005260:Female; D005348:Fibrocystic Breast Disease / Q000150:complications / Q000453:epidemiology* / Q000378:metabolism; D006062:Gonadotropins / Q000378:metabolism; D006728:Hormones / Q000378:metabolism*; D006801:Humans; D007774:Lactation; D008875:Middle Aged; D009765:Obesity; D010298:Parity; D011247:Pregnancy; D011374:Progesterone / Q000378:metabolism; D011388:Prolactin / Q000378:metabolism; D011453:Prostaglandins / Q000378:metabolism; D044469:Racial Groups; D011960:Receptors, Estrogen / Q000378:metabolism; D012306:Risk; D012959:Socioeconomic Factors; D014970:Xanthines / Q000009:adverse effects
D000728:Androgens; D002272:Carcinoembryonic Antigen; D003276:Contraceptives, Oral; D004967:Estrogens; D006062:Gonadotropins; D006728:Hormones; D011453:Prostaglandins; D011960:Receptors, Estrogen; D014970:Xanthines; D011374:Progesterone; D011388:Prolactin